title: Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment.
authors.forename: Laurent
authors.initials: L
authors.lastname: Alric
authors.forename: Delphine
authors.initials: D
authors.lastname: Bonnet
authors.forename: Odile
authors.initials: O
authors.lastname: Beynes-Rauzy
authors.forename: Jacques
authors.initials: J
authors.lastname: Izopet
authors.forename: Nassim
authors.initials: N
authors.lastname: Kamar
mesh_terms: D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000906:Antibodies / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002908:Chronic Disease; D005260:Female; D016751:Hepatitis E / Q000175:diagnosis* / Q000188:drug therapy*; D016752:Hepatitis E virus / Q000187:drug effects* / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D015477:Leukemia, Myelomonocytic, Chronic / Q000150:complications; D012254:Ribavirin / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000150:complications; D016896:Treatment Outcome; D019562:Viral Load / Q000187:drug effects
chemical_list: D000906:Antibodies; D000998:Antiviral Agents; D015415:Biomarkers; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D012254:Ribavirin; D000410:Alanine Transaminase